Cargando…

Seattle protocol vs narrow band imaging guided biopsy in screening of Barrett's esophagus in gastroesophageal reflux disease patients

Barrett's esophagus has 0.5% to 7% risk of progression to esophageal adenocarcinoma. The method of obtaining biopsies to diagnose Barrett's is challenging. Seattle protocol has been considered as the gold standard, however its difficulty limits its applicability in practice. Narrow band im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elsheaita, Ahmed, El-Bially, Mohamed Ahmed, Shamseya, Mohammed Mohammed, Ahmed, Sanaa Shawky, Madkour, Marwa Ahmed, Shamseya, Ayman Mohammed, Nouh, Hanan Hosny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034706/ https://www.ncbi.nlm.nih.gov/pubmed/32080134 http://dx.doi.org/10.1097/MD.0000000000019261

Ejemplares similares

Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

The clinical significance of serum miRNA-224 expression in hepatocellular carcinoma
por: Nomair, Azhar Mohamed, et al.
Publicado: (2020)

Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma
por: Nomair, Azhar Mohamed, et al.
Publicado: (2019)

MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes
por: Elemeery, Moustafa Nouh, et al.
Publicado: (2019)

Simplified Classification of Capillary Pattern in Barrett Esophagus Using Magnifying Endoscopy With Narrow Band Imaging: Implications for Malignant Potential and Interobserver Agreement
por: Uno, Goichi, et al.
Publicado: (2015)

β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study
por: Lashen, Sameh A, et al.
Publicado: (2022)

Laparoscopic revision surgery for gastroesophageal reflux disease
por: Celasin, Haydar, et al.
Publicado: (2017)

Peroral endoscopic cardial constriction in gastroesophageal reflux disease
por: Hu, Hai-Qing, et al.
Publicado: (2018)

Metabolic syndrome is associated with increased risk of Barrett esophagus: A meta-analysis
por: He, Qiong, et al.
Publicado: (2016)

Helicobacter pylori infection and gastroesophageal reflux disease - Barrett’s esophagus sequence “dilemma”
por: Kountouras, Jannis, et al.
Publicado: (2015)

Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease
por: Ye, Bi Xing, et al.
Publicado: (2017)

Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis
por: Guo, Zihao, et al.
Publicado: (2021)

Association between gastroesophageal reflux disease and vocal fold polyps
por: Zou, Yazhu, et al.
Publicado: (2021)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Association Between Alcohol Consumption and the Risk of Barrett's Esophagus: A Meta-Analysis of Observational Studies
por: Xu, Qin, et al.
Publicado: (2015)

Prevalence, clinical characteristics, and risk factors of Barrett esophagus in Vietnamese patients with upper gastrointestinal symptoms
por: Quach, Duc T., et al.
Publicado: (2020)

Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence?
por: Hwang, Jae Jin, et al.
Publicado: (2015)

Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus
por: Gharahkhani, Puya, et al.
Publicado: (2016)

Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
por: Mikolašević, Ivana, et al.
Publicado: (2018)

Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening
por: Yang, Yu, et al.
Publicado: (2015)

Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening
por: Yang, Yu, et al.
Publicado: (2015)

The Prevalence of Barrett Esophagus Diagnosed in the Second Endoscopy: A Retrospective, Observational Study at a Tertiary Center
por: Suna, Nuretdin, et al.
Publicado: (2016)

Clinical variation in surveillance and management of Barrett’s esophagus: A cross-sectional study of gastroenterologists and gastrointestinal surgeons
por: Cruz, Jamielyn DC, et al.
Publicado: (2022)

Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis
por: Yang, Yue, et al.
Publicado: (2016)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

The prevalence of coronary atherosclerosis in patients with refractory gastroesophageal reflux disease ready for antireflux surgery
por: Zhang, Xiumei, et al.
Publicado: (2022)

Molecular Profile of Barrett’s Esophagus and Gastroesophageal Reflux Disease in the Development of Translational Physiological and Pharmacological Studies
por: Korbut, Edyta, et al.
Publicado: (2020)

Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case–control study
por: van Olphen, Sophie H., et al.
Publicado: (2016)

Benefits of the Seattle biopsy protocol in the diagnosis of Barrett’s esophagus in a Chinese population
por: Lee, Shou-Wu, et al.
Publicado: (2018)

Laparoscopic fundoplication in treating refractory gastroesophageal reflux-related chronic cough: A meta-analysis
por: Liu, Jiannan, et al.
Publicado: (2023)

Association between gastroesophageal reflux disease and coronary heart disease: A nationwide population-based analysis
por: Chen, Chien-Hua, et al.
Publicado: (2016)

Association between gastroesophageal reflux disease and depression disorder: A protocol for systematic review and meta-analysis
por: Liu, Yu, et al.
Publicado: (2020)

Gastroesophageal Reflux in Relation to Adenocarcinomas of the Esophagus: A Pooled Analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)
por: Cook, Michael B., et al.
Publicado: (2014)

An improved surgical procedure to establish a gastroesophageal reflux model with a high incidence of Barrett's esophagus in rats
por: Wen, Hui, et al.
Publicado: (2018)

Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus
por: Baldaque-Silva, Francisco, et al.
Publicado: (2017)

Causal relationship between gastroesophageal reflux disease, Barrett's esophagus, and epilepsy: A bidirectional Mendelian randomization study
por: Liu, Xiaoduo, et al.
Publicado: (2023)

An analysis of 342 patients with refractory gastroesophageal reflux disease symptoms using questionnaires, high-resolution manometry, and impedance-pH monitoring
por: Wang, Fei, et al.
Publicado: (2017)

Gastroesophageal Reflux Induces Protein Adducts in the Esophagus
por: Caspa Gokulan, Ravindran, et al.
Publicado: (2018)

Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett’s Esophagus in a Population-Based Case-Control Study
por: Lindam, Anna, et al.
Publicado: (2015)

Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study
por: Cho, Jae Ho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ec8baog6jh8hpq0fjf2a2dfpqb